NDRI is Pleased to Announce Recent Projects Funded by the NIH
Funded: August 8, 2006
Project Title: HIV/STD Infection in an Urban High Risk Population
Supplement Grant Number: 3 R01 DA018080-03S1
NDRI Principal Investigator: Larry Nuttbrock, PhD
This two year NIH funding supports the post-doctoral research career of Dr. Sel Hwahng under the NIH Research Supplements to Promote Diversity in Health-Related Research. The supplement augments Dr. Larry Nuttbrock’s parent project R01 DA018080.
Funded: August 21, 2006
Project Title: Transient Domesticity & Violence in Distressed Households
Supplement Grant Number: 3 R01 DA009056-12S1
Principal Investigator: Eloise Dunlap, PhD
This two year NIH funding supports the pre-doctoral research career of Liliane Windsor at the University of Texas at Austin’s School of Social Work Doctoral Degree Program in collaboration with Dissertation Chair, Dr. Marilyn Peterson Armour. The supplement under the NIH Research Supplements to Promote Diversity in Health-Related Research augments Dr. Eloise Dunlap’s parent project R01 DA009056.
Funded: September 20, 2006
Project Title: Computer-Delivery of Effective, Psychosocial Interventions in Methadone Treatment
Grant Number: R01 DA021818
Principal Investigator: Lisa Marsch, PhD
This NIDA project (R01 DA021818) extends the prior research of Dr. Lisa Marsch to evaluate the effectiveness and cost-effectiveness of a science-based, computer-delivered psychosocial intervention for patients in methadone treatment. This interactive, self-directed Therapeutic Education System is theoretically grounded in the evidence-based Community Reinforcement Approach to psychosocial treatment.
Funded: September 25, 2006
Project Title: Sublingual Buprenorphine for Chronic Pain in Patients at Risk for Drug Abuse
Grant Number: R21 DA022675
Principal Investigator: Andrew Rosenblum, PhD
The aims of this NIDA Exploratory/Developmental Research Grant (R21 DA022675) led by Drs. Andrew Rosenblum and Russell Portenoy are: 1) To create a protocol for the use of SL buprenorphine for the treatment of chronic pain in populations at risk for substance use disorders. This protocol will be developed by an expert panel comprising leaders in pain medicine, addiction medicine and buprenorphine pharmacology. 2) To evaluate this protocol in regards to its feasibility and a range of outcomes related to safety and effectiveness.
Funded: September 30, 2006
Project Title: Supporting Alcohol Reduction in HIV+ Patients: A Training for HIV Care Providers
Grant Number: R21 AA016743
Principal Investigator: Shiela Strauss, PhD
This Exploratory/Developmental Research Grant (R21 AA016743) led by Dr. Shiela Strauss aims to develop and evaluate a theory-driven training for HIV care providers to support their systematic use of the National Institute on Alcohol Abuse and Alcoholism's Brief Intervention for alcohol reduction.
November, 2006




